{
    "SPADE_UN_11878": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_11878",
            "Peptide Name": "AMP72 (De novo synthesis)",
            "Source": "Synthetic construct",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "KGCALVKVRGLTLKVCK",
            "Sequence Length": 17,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Synthetic form",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "[Ref.23893489] Gram-positive bacteria :Staphylococcus aureus(MBC=6.88 μg/ml, 3.78 μM), MRSA(MBC=1.72 μg/ml, 0.94 μM), Streptococcus agalactiae(MBC>55 μg/ml, 100 μM);Gram-negative bacteria :Pseudomonas aeruginosa(MBC=3.30 μg/ml, 1.81 μM), Escherichia coli(MBC=3.40 μg/ml, 1.87 μM), Salmonella enteritidis(MBC=3.20 μg/ml, 1.76 μM), Stenotrophomonas maltophilia(MBC=18.5 μg/ml, 10.19 μM)",
            "Hemolytic Activity": "[Ref.23893489] <1% hemolysis at 1 μg/ml , <1% hemolysis at 12.5 μg/ml , 1.5% hemolysis at 100 μg/ml , 4.2% hemolysis at 250 μg/ml , 12.0% hemolysis at 500 μg/ml against sheep red blood cells",
            "Cytotoxicity": "[Ref.23893489] The cytotoxicity (vs control) of P72 is 3% against HUVEC (endothelial) cells at a peptide concentration of 100 μg/ml.The cytotoxicity (vs control) of P72 is 4% agaisnt WI-38 (fibroblast) cells at a peptide concentration of 100 μg/ml. #",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C80H150N24O19S2",
            "Mass": 1816.33,
            "PI": 10.07,
            "Net Charge": 5,
            "Hydrophobicity": 0.54,
            "Half Life": "Mammalian:1.3 hourYeast:3 minE.coli:2 min",
            "Function": "Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria",
            "Literature": [
                {
                    "Title": "In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.",
                    "Pubmed ID": "23893489",
                    "Reference": "J Pept Sci. 2013 Sep;19(9)554-65. doi 10.1002/psc.2532.",
                    "Author": "Romani AA, Baroni MC, Taddei S, Ghidini F, Sansoni P, Cavirani S, Cabassi CS",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=23893489"
                },
                {
                    "Title": "In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens",
                    "Pubmed ID": "",
                    "Author": "Romani AA, Baroni MC, Taddei S, Ghidini F, Sansoni P, Cavirani S, Cabassi CS"
                }
            ],
            "Frequent Amino Acids": "KLV",
            "Absent Amino Acids": "DEFHIMNOPQSUWY",
            "Basic Residues": 5,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 7,
            "Polar Residues": 12,
            "Positive Residues": 5,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_13743",
                    "Similarity": 0.6666666666666666,
                    "Sequence": "TLKVVVKVVKYLV"
                },
                {
                    "SPADE_ID": "SPADE_UN_18239",
                    "Similarity": 0.625,
                    "Sequence": "LVKVKVLL"
                },
                {
                    "SPADE_ID": "SPADE_UN_00499",
                    "Similarity": 0.6153846153846154,
                    "Sequence": "CVKVRVKVGSGVKVRVKVC"
                }
            ]
        }
    }
}